In vitro activity of proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2472-2474

  Pascual, Aurélie ^a   Henry, Maud ^a   Briolant, Sébastien ^a   Charras, Serge ^a   Baret, Eric ^a   Amalvict, Rémy ^a   Des Etages, Emilie Huyghues ^b   Feraud, Michel ^b   Rogier, Christophe ^a   Pradines, Bruno ^a  

^a INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^b Provepharm SAS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BENFLUMETOL; CHLOROQUINE; DEETHYLAMODIAQUINE; DIHYDROARTEMISININ; MEFLOQUINE; METHYLENE BLUE; QUININE;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; COPY NUMBER VARIATION; DRUG INHIBITION; IC 50; IN VITRO STUDY; MICROBIAL GENETICS; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79955526843     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01466-10     Document Type: Article

References (28)

1. Ademowo, O. G., C. M. Nneji, and A. D. A. Adedapo. 2007. In vitro antimalarial activity of methylene blue against field isolates of Plasmodium falciparum from children in Southwest Nigeria. Indian J. Med. Res. 126:45-49.
2. Akoachere, M., et al. 2005. In vitro assessment of methylene blue on chloroquine-sensitive and-resistant Plasmodium falciparum strains reveals synergistic action with artemisinins. Antimicrob. Agents Chemother. 49:4592-4597.
3. Alibert-Franco, S., B. Pradines, A. Mahamoud, A. Davin-Regli, and J. M. Pagès. 2009. Efflux mechanism, an attractive target to combat multidrug resistant Plasmodium falciparum and Pseudomonas aeruginosa. Curr. Med. Chem. 16:301-317.
4. Anonymous. 1900. Methylene blue in grave malaria cachexia. JAMA 34:1409.
5. Atamna, H., et al. 1996. Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo. Biochem. Pharmacol. 51:693-700.
6. Bogreau, H., et al. 2006. Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Am. J. Trop. Med. Hyg. 74:953-959.
7. Coulibaly, B., et al. 2009. Strong gametocytocidal effect of methylene bluebased combination therapy against falciparum malaria: a randomized controlled trial. PLoS One 4:5318.
8. Dokomajilar, C., S. L. Nsobya, B. Greenhouse, P. J. Rosenthal, and G. Dorsey. 2006. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob. Agents Chemother. 50:1893-1895.
9. Ferdig, M. T., et al. 2004. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52:985-997.
10. Garavito, G., et al. 2007. Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum. Parasite 14:135-140. (Pubitemid 46996359)
11. Guttmann, P., and P. Ehrlich. 1891. Ueber die wirkung des methylenblau bei malaria. Berlin Klin. Wochenschr. 28:953-956.
12. Henry, M., et al. 2006. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am. J. Trop. Med. Hyg. 75:146-151.
13. Henry, M., S. Alibert, C. Rogier, J. Barbe, and B. Pradines. 2008. Inhibition of efflux of quinolines as new therapeutic strategy in malaria. Curr. Top. Med. Chem. 8:563-568.
14. Henry, M., et al. 2006. Chloroquine resistance reversal agents as promising antimalarial drugs. Curr. Drug Targets 7:935-948. (Pubitemid 44227578)
15. Henry, M., et al. 2008. In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum. Antimicrob. Agents Chemother. 52:2755-2759.
16. + exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob. Agents Chemother. 53:1926-1930.
17. Mandi, G., et al. 2005. Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. Trop. Med. Int. Health 10:32-38.
18. Meissner, P. E., et al. 2008. Marked difference in the prevalence of chloroquine resistance between urban and rural communities in Burkina Faso. Acta Trop. 105:81-86. (Pubitemid 350262797)
19. Meissner, P. E., et al. 2006. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malar. J. 5:84.
20. Meissner, P. E., et al. 2005. Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]. Malar. J. 4:45.
21. Parquet, V., et al. 2009. Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria. Antimicrob. Agents Chemother. 53:2248-2252.
22. Pradines, B., et al. 2010. Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg. Infect. Dis. 16:546-548.
23. Price, R. N., et al. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447. (Pubitemid 39036891)
24. Ursing, J., P. E. Kofoed, A. Rodrigues, L. Rombo, and J. P. Gil. 2007. Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. Am. J. Trop. Med. Hyg. 76:844-848.
25. Ursing, J., S. Zakeri, J. P. Gil, and A. Bjorkman. 2006. Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran. Acta Trop. 97:352-356.
26. Vennerstrom, J. L., M. T. Mackler, C. K. Angerhofer, and J. A. Williams. 1995. Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines. Antimicrob. Agents Chemother. 39:2671-2677.
27. Wurtz, N., et al. 2010. Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene. J. Antimicrob. Chemother. 65:1387-1394.
28. Zoungrana, A., et al. 2008. Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS One 3:1630.